Acetyl-L-carnitine cytoprotection against 1-methyl-4-phenylpyridinium toxicity in neuroblastoma cells

Biochemical Pharmacology

Volumn 66, Issue 2, 2003, Pages 297-306

  Mazzio, Elizabeth ^a   Yoon, Kyoung J ^a   Soliman, Karam F A ^a  

^a FLORIDA A AND M UNIVERSITY   (United States)

Author keywords

Acetyl L carnitine; Energy; Metabolism; MPP; MPTP; Parkinson's disease

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; 1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; ADENOSINE TRIPHOSPHATE; CARNITINE; FATTY ACID; GLUCOSE; INSULIN; LEVACECARNINE; MALONYL COENZYME A; OXYGEN;

ANAEROBIC GLYCOLYSIS; ANIMAL CELL; ARTICLE; CELL LEVEL; CELL METABOLISM; CELL PROTECTION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; ENERGY; FATTY ACID OXIDATION; FATTY ACID TRANSPORT; GLUCOSE UTILIZATION; METABOLITE; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; NEUROBLASTOMA CELL; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATIVE PHOSPHORYLATION; OXYGEN CONSUMPTION; PRIORITY JOURNAL; RAT;

EID: 0038433337     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(03)00261-2     Document Type: Article

References (49)

1. Fritz I.B., Marquis N.R. The role of acylcarnitine esters and carnitine palmityltransferase in the transport of fatty acyl groups across mitochondrial membranes. Proc. Natl. Acad. Sci. U.S.A. A54:1965;1226-1233.
2. Dolezal V., Tucek S. Utilization of citrate, acetylcarnitine acetate, pyruvate and glucose for the synthesis of acetylcholine in rat brain slices. J. Neurochem. 36:1981;1323-1330.
3. Burlina A.P., Sershen H., Debler E.A., Lajtha A. Uptake of acetyl-L-carnitine in the brain. Neurochem. Res. 14:1989;489-493.
4. Pettegrew J.W., Klunk W.E., Panchalingam K., Kanfer J.N., McClure R.J. Clinical and neurochemical effects of acetyl-L-carnitine in Alzheimer's disease. Neurobiol. Aging. 16:1995;1-4.
5. Pettegrew J.W., Levine J., McClure R.J. Acetyl-L-carnitine physical-chemical, metabolic, and therapeutic properties: relevance for its mode of action in Alzheimer's disease and geriatric depression. Mol. Psychiatry. 5:2000;616-632.
6. Spagnoli A., Lucca U., Menasce G., Bandera L., Cizza G., Forloni G., Tettamanti M., Frattura L., Tiraboschi P., Comelli M., Senin U., Longo A., Petrinin A., Brambilla G., Belloni A., Negri C., Cavazzuti F., Salsi A., Calogero P., Parma E., Stramb-Badiale M., Vitali S., Andreoni G., Inzoli M.R., Santus G., Caregnato R., Peruzza M., Favaretto M., Bozeglav C., Alberoni M., De Leo D., Serraiotto L., Baiocchi L., Soccia S., Culotta P., Leracitano D. Long-term acetyl-L-carnitine treatment in Alzheimer's disease. Neurology. 41:1991;1726-1732.
7. Liu J., Head E., Gharib A.M., Yuan W., Ingersoll R.T., Hagen T.M., Cotman C.W., Ames B.N. Memory loss in old rats is associated with brain mitochondrial decay and RNA/DNA oxidation: partial reversal by feeding acetyl-L-carnitine and/or R-alpha-lipoid acid. Proc. Natl. Acad. Sci. U.S.A. 99:2002;2356-2361.
8. Ando S., Tadenuma T., Tanaka Y., Fukui F., Kobayashi S., Ohashi Y., Kawabata T. Enhancement of learning capacity and cholinergic synaptic function by carnitine in aging rats. J. Neurosci. Res. 66:2001;266-271.
9. Virmani M.A., Caso V., Spadoni A., Rossi S., Russo F., Gaetani F. The action of acetyl-L-carnitine on the neurotoxicity evoked by amyloid fragments and peroxide on primary rat cortical neurons. Ann. N.Y. Acad. Sci. 939:2001;162-178.
10. Thal L.J., Calvani M., Amato A., Carta A.A. 1-year controlled trial of acetyl-L-carnitine in early-onset AD. Neurology. 55:2000;805-810.
11. Orth M., Schapira A.H. Mitochondrial involvement in Parkinson's disease. Neurochem. Int. 40:2002;533-541.
12. Gu M., Owen A.D., Toffa S.E., Cooper J.M., Dexter D.T., Jenner P., Marsden C.D., Schapira A.H. Mitochondrial function GSH and iron in neurodegeneration and Lewy body diseases. J. Neurol. Sci. 158:1998;24-29.
13. Gadaleta M.N., Cormio A., Pesce V., Lezza A.M., Cantatore P. Aging and mitochondria. Biochimie. 80:1998;863-870.
14. Hagen T.M., Wehr C.M., Ames B.N. Mitochondrial decay in aging. Reversal through supplementation of acetyl-L-carnitine and N-tert-butyl-alpha-phenyl-nitrone. Ann. N.Y. Acad. Sci. 854:1998;214-223.
15. Hagen T.M., Moreau R., Suh J.H., Visioli F. Mitochondrial decay in the aging rat heart: evidence for improvement by dietary supplementation with acetyl-L-carnitine and/or lipoic acid. Ann. N.Y. Acad. Sci. 959:2002;491-507.
16. Kaur J., Sharma D., Singh R. Acetyl-L-carnitine enhances Na(+) K(+)-ATPase glutathione-S-transferase and multiple unit activity and reduces lipid peroxidation and lipofuscin concentration in aged rat brain regions. Neurosci. Lett. 301:2001;1-4.
17. Bodis-Wollner I., Chung E., Ghilardi M.F., Glover A., Onofrj M., Pasik P., Samson Y. Acetyl-levo-carnitine protects against MPTP-induced Parkinsonism in primates. J. Neural. Transm. (Parkinson's Disease Dementia Sect.). 3:1991;63-72.
18. Pileblad E., Carlsson A. Catecholamine-uptake inhibitors prevent the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mouse brain. Neuropharmacology. 24:1985;689-692.
19. Bradbury A.J., Costall B., Jenner P.G., Kelly M.E., Marsden C.D., Naylor R.J. The effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on striatal and limbic catecholamine neurons in white and black mice. Antagonism by monoamine oxidase inhibitors. Neuropharmacology. 25:1986;897-904.
20. + in vitro: characterization using specific cell lines. Brain Res. 456:1988;254-262.
21. + and rotenone in neural cell lines. Toxicologist. 11:1991;313.
22. O'Brien J., Wilson I., Orton T., Pognan F. Investigation of the Alamar Blue resazurin fluorescent dye for the assessment of mammalian cell cytotoxicity. Eur. J. Biochem. 267:2000;5421-5426.
23. Yamane N., Behiry I.K., Tosaka M., Nakasone I. Determination of in vitro synergy when amphotericin B is combined with various antimicrobial agents against yeasts by using a colorimetric microdilution checkerboard. Rinsho Byori. 45:1997;689-696.
24. Visser W., Scheffers W.A., Batenburg-van der Vegte W.H., van Dijken J.P. Oxygen requirements of yeasts. Appl. Environ. Microbiol. 56:1990;3785-3792.
25. Evans S.M., Casartelli A., Herreros E., Minnick D.T., Day C., George E., Westmoreland C. Development of a high throughput in vitro toxicity screen predictive of high acute in vivo toxic potential. Toxicol. In Vitro. 15:2001;579-584.
26. Jones K.H., Senft J.A. An improved method to determine cell viability by simultaneous staining with fluorescein diacetate-propidium iodide. Cytochemistry. 33:1985;77-79.
27. Naslund B., Arner P., Bolinder J., Hallander L., Lundin A. Glucose determination in samples taken by microdialysis by peroxidase-catalyzed luminal chemiluminescence. Anal. Biochem. 192:1991;237-242.
28. Holt A., Sharman D.F., Baker G.B., Palcic M.M. A continuous spectrophotometric assay for monoamine oxidase and related enzymes in tissue homogenates. Anal. Biochem. 244:1997;384-392.
29. Lowry O.J., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
30. Virmani M.A., Biselli R., Spadoni A., Rossi S., Corsico N., Calvani M., Fattorossi A., De Simone C., Arrigoni-Martelli E. Protective actions of L-carnitine and acetyl-L-carnitine on the neurotoxicity evoked by mitochondrial uncoupling or inhibitors. Pharmacol. Res. 32:1995;383-389.
31. Blokland A., Bothmer J., Honig W., Jolles J. Behavioral and biochemical effects of acute central metabolic inhibition: effects of acetyl-L-carnitine. Euro. J. Pharmacol. 235:1993;275-281.
32. Calvani M., Arrigoni-Martelli E. Attenuation by acetyl-L-carnitine of neurological damage and biochemical derangement following brain ischemia and reperfusion. Int. J. Tissue React. 21:1999;1-6.
33. Ebadi M., Govitrapong P., Sharma S., Muralikrishnan D., Shavali S., Pellett L., Schafer R., Albano C., Eken J. Ubiquinone (coenzyme q10) and mitochondria in oxidative stress of Parkinson's disease. Biol. Signals Recept. 10:2001;224-253.
34. Greenamyre J.T., MacKenzie G., Peng T.I., Stephans S.E. Mitochondrial dysfunction in Parkinson's disease. Biochem. Soc. Symp. 66:1999;85-97.
35. Sherer T.B., Trimmer P.A., Borland K., Parks J.K., Bennett J.P. Jr., Tuttle J.B. Chronic reduction in complex I function alters calcium signaling in SH-SY5Y neuroblastoma cells. Brain Res. 891:2001;94-105.
36. Cassarino D.S., Halvorsen E.M., Swerdlow R.H., Abramova N.N., Parker W.D. Jr., Sturgill T.W., Bennett J.P. Jr. Interaction among mitochondria, mitogen-activated protein kinases, and nuclear factor-kappa B in cellular models of Parkinson's disease. J. Neurochem. 74:2000;1384-1392.
37. Mazzio E., Soliman K.F.A. D-(+)-Glucose rescue against 1-methyl-4-phenylpyridinium toxicity through anaerobic glycolysis in neuroblastoma cells. Brain Res. 962:2003;48-60.
38. +-induced apoptosis depends on mitochondrial membrane potential and ATP synthase. Biochem. Biophys. Res. Commun. 257:1999;440-447.
39. Storch A., Kaftan A., Burkhardt K., Schwarz J. 1-Methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (salsolinol) is toxic to dopaminergic neuroblastoma SH-SY5Y cells via impairment of cellular energy metabolism. Brain Res. 855:2000;67-75.
40. Aureli T., Di Cocco M.E., Puccetti C., Ricciolini R., Scalibastri M., Miccheli A., Manetti C., Conti F. Acetyl-L-carnitine modulates glucose metabolism and stimulates glycogen synthesis in rat brain. Brain Res. 796:1998;75-81.
41. Paradies G., Petrosillo G., Gadaleta M.N., Ruggiero F.M. The effect of aging and acetyl-L-carnitine on the pyruvate transport and oxidation in rat heart mitochondria. FEBS Lett. 454:1999;207-209.
42. Taglialatela G., Navarra D., Olivi A., Ramacci M.T., Werrbach-Perez K., Perez-Polo J.R., Angelucci L. Neurite outgrowth in PC12 cells stimulated by acetyl-L-carnitine arginine amide. Neurochem. Res. 20:1995;1-9.
43. Foreman P.J., Perez-Polo J.R., Angelucci L., Ramacci M.T., Taglialatela G. Effects of acetyl-L-carnitine treatment and stress exposure on the nerve growth factor receptor (p75NGFR) mRNA level in the central nervous system of aged rats. Prog. Neuropsychopharmacol. Biol. Psychiatry. 19:1995;117-133.
44. Mazzio E., Soliman K.F.A. The role of glycolysis and gluconeogenesis in the cytoprotection of neuroblastoma cells against 1-methyl 4-phenylpyridinium ion toxicity. Neurotoxicology. 24:2003;137-147.
45. Hassel B. Carboxylation and anaplerosis in neurons and glia. Mol. Neurobiol. 22:2000;21-40.
46. Hassel B. Pyruvate carboxylation in neurons. J. Neurosci. Res. 66:2001;755-762.
47. Cruz F., Scott S.R., Barroso I., Santisteban P., Cerdan S. Ontogeny and cellular localization of the pyruvate recycling system in rat brain. J. Neurochem. 70:1998;2613-2619.
48. McKenna M.C., Stevenson J.H., Huang X., Tildon J.T., Zielke C.L., Hopkins I.B. Mitochondrial malic enzyme activity is much higher in mitochondria from cortical synaptic terminals compared with mitochondria from primary cultures of cortical neurons or cerebellar granule cells. Neurochem. Int. 36:2000;451-459.
49. Suormala T., Wiesmann U.N., Cruz F., Wolf A., Daschner M., Limat A., Fowler B., Baumgartner E.R. Biotin-dependent carboxylase activities in different CNS and skin-derived cells, and their sensitivity to biotin-depletion. Int. J. Vitam. Nutr. Res. 72:2002;278-286.